Alison McGough Holliday, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Students, Dental | 2 | 2019 | 160 | 1.230 |
Why?
|
Students, Medical | 2 | 2019 | 1862 | 0.560 |
Why?
|
Geriatrics | 1 | 2019 | 396 | 0.510 |
Why?
|
Quality Indicators, Health Care | 1 | 2017 | 1831 | 0.280 |
Why?
|
Quality Improvement | 1 | 2019 | 3749 | 0.240 |
Why?
|
Internet | 1 | 2017 | 3064 | 0.240 |
Why?
|
Patient Satisfaction | 1 | 2017 | 3396 | 0.240 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2020 | 249 | 0.160 |
Why?
|
Self Efficacy | 1 | 2019 | 616 | 0.130 |
Why?
|
Information Seeking Behavior | 1 | 2017 | 113 | 0.130 |
Why?
|
Physicians, Primary Care | 1 | 2018 | 591 | 0.100 |
Why?
|
Education, Medical, Undergraduate | 1 | 2019 | 1008 | 0.090 |
Why?
|
Perception | 1 | 2017 | 1198 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3952 | 0.090 |
Why?
|
Massachusetts | 2 | 2018 | 8663 | 0.070 |
Why?
|
Curriculum | 1 | 2019 | 3605 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2018 | 3528 | 0.060 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2018 | 2208 | 0.060 |
Why?
|
Physician-Patient Relations | 1 | 2017 | 3229 | 0.060 |
Why?
|
Prevalence | 1 | 2019 | 15226 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Electronic Health Records | 1 | 2018 | 4468 | 0.050 |
Why?
|
Pneumocystis carinii | 1 | 2020 | 74 | 0.040 |
Why?
|
Lymphopenia | 1 | 2020 | 285 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2017 | 25043 | 0.030 |
Why?
|
Urinalysis | 1 | 2018 | 369 | 0.030 |
Why?
|
Nephrology | 1 | 2018 | 263 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2020 | 2559 | 0.030 |
Why?
|
Humans | 6 | 2023 | 744343 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2023 | 5078 | 0.030 |
Why?
|
Female | 4 | 2020 | 380194 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2018 | 924 | 0.030 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1518 | 0.020 |
Why?
|
Aged | 3 | 2020 | 163280 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2018 | 2266 | 0.020 |
Why?
|
Middle Aged | 2 | 2018 | 213383 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3923 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2018 | 4371 | 0.010 |
Why?
|
Male | 2 | 2018 | 350118 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7279 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8388 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 57776 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 72290 | 0.010 |
Why?
|